Grantham, Mayo, Van Otterloo & Co (GMO)’s Novartis NVS Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $42.7M | Sell |
|
|||||
|
2025
Q1 | $43.7M | Sell |
|
|||||
|
2024
Q4 | $56.2M | Sell |
|
|||||
|
2024
Q3 | $76.5M | Sell |
|
|||||
|
2024
Q2 | $83M | Sell |
|
|||||
|
2024
Q1 | $91.5M | Sell |
|
|||||
|
2023
Q4 | $154M | Sell |
|
|||||
|
2023
Q3 | $186M | Buy |
|
|||||
|
2023
Q2 | $68.9M | Buy |
|
|||||
|
2023
Q1 | $938K | Sell |
|
|||||
|
2022
Q4 | $4.08M | Buy |
|
|||||
|
2022
Q2 | – | Sell |
|
|||||
|
2022
Q1 | $307K | Sell |
|
|||||
|
2021
Q4 | $17.1M | Buy |
|
|||||
|
2021
Q3 | $13.3M | Buy |
|
|||||
|
2021
Q2 | $274K | Buy |
|
|||||
|
2019
Q3 | – | Sell |
|
|||||
|
2019
Q2 | $411K | Sell |
|
|||||
|
2019
Q1 | $586K | Sell |
|
|||||
|
2018
Q4 | $901K | Sell |
|
|||||
|
2018
Q3 | $1.47M | Sell |
|
|||||
|
2018
Q2 | $1.47M | Buy |
|